Effect of pre-transplant cytoreductive therapy on the outcomes of patients with MDS or secondary AML evolving from MDS undergoing allo-HSCT: a secondary analysis of an RCT
移植前细胞减灭疗法对接受异基因造血干细胞移植的MDS或继发于MDS的AML患者预后的影响：一项随机对照试验的二次分析
期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/s41408-025-01233-9
Xue, Rongtao; Dai, Min; Jiang, Erlie; Ou, Xueying; Huang, Fen; Fan, Zhiping; Xu, Na; Yan, Chenhua; Nie, Danian; Liang, Xinquan; Chen, Hong; Ye, Jieyu; Jiang, Ling; Liu, Hui; Jin, Hua; Lin, Ren; Zhang, Yu; Sun, Jing; Han, Mingzhe; Liu, Qifa; Wang, Yu; Xuan, Li
